[HTML][HTML] Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study

YL Wu, ZJ Lin, CC Li, X Lin, SK Shan, B Guo… - … and Targeted Therapy, 2023 - nature.com
Epigenetics regulates gene expression and has been confirmed to play a critical role in a
variety of metabolic diseases, such as diabetes, obesity, non-alcoholic fatty liver disease …

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Q Zhong, X Xiao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …

[HTML][HTML] SGLT2 inhibitors in the treatment of diabetic kidney disease: more than just glucose regulation

J Klen, V Dolžan - Pharmaceutics, 2023 - mdpi.com
Diabetic kidney disease (DKD) is a severe and common complication and affects a quarter
of patients with type 2 diabetes mellitus (T2DM). Oxidative stress and inflammation related to …

[HTML][HTML] Ketone bodies as metabolites and signalling molecules at the crossroad between inflammation and epigenetic control of cardiometabolic disorders

N Bendridi, A Selmi, A Balcerczyk, L Pirola - International journal of …, 2022 - mdpi.com
For many years, it has been clear that a Western diet rich in saturated fats and sugars
promotes an inflammatory environment predisposing a person to chronic cardiometabolic …

Orthogonal Translation for Site-Specific Installation of Post-translational Modifications

Q Gan, C Fan - Chemical Reviews, 2024 - ACS Publications
Post-translational modifications (PTMs) endow proteins with new properties to respond to
environmental changes or growth needs. With the development of advanced proteomics …

[HTML][HTML] Β-hydroxybutyrate: A crucial therapeutic target for diverse liver diseases

K Li, W Wang, J Wu, W Xiao - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Abstract β-hydroxybutyrate (β-HB), the most abundant ketone body, is produced primarily in
the liver and acts as a substitute energy fuel to provide energy to extrahepatic tissues in the …

[HTML][HTML] Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases

J Jang, SR Kim, JE Lee, S Lee, HJ Son… - International journal of …, 2023 - mdpi.com
Ketone bodies (KBs), such as acetoacetate and β-hydroxybutyrate, serve as crucial
alternative energy sources during glucose deficiency. KBs, generated through ketogenesis …

[HTML][HTML] Epigenetic meets metabolism: novel vulnerabilities to fight cancer

D Scumaci, Q Zheng - Cell Communication and Signaling, 2023 - Springer
Histones undergo a plethora of post-translational modifications (PTMs) that regulate
nucleosome and chromatin dynamics and thus dictate cell fate. Several evidences suggest …

Ketogenic metabolic therapy for chronic kidney disease–the pro part

T Weimbs, J Saville, K Kalantar-Zadeh - Clinical Kidney Journal, 2024 - academic.oup.com
Ketogenic metabolic therapy (KMT) is a medical nutrition therapy to address certain health
and disease conditions. It is increasingly used for many non-communicable diseases that …

[HTML][HTML] Impact of fasting & ketogenic interventions on the NLRP3 inflammasome: A narrative review

H Neudorf, JP Little - Biomedical Journal, 2023 - Elsevier
Overactivation of the NLRP3 inflammasome is implicated in chronic low-grade inflammation
associated with various disease states, including obesity, type 2 diabetes, atherosclerosis …